Managing Investigator Initiated Research
US$ 595.00
... , and a fresh perspective on stakeholders’ roles and responsibilities. Report Overview Managing Investigator-Initiated Research This comprehensive report brings together industry data, exclusive ... end-to-end IIR programme management Who Would Benefit From This Report? Managers and Executives with responsibilities in: Investigator-initiated research (IIR) programmes Branding ...
April 2012
74 pages
Nutritional Supplements Market Report: 2012 Edition
US$ 800.00
... other countries like France and Denmark. The report provides an analysis of the global nutritional supplements market. It also discusses the major trends, ... growth drivers and challenges for the market. The report presents the ...
April 2012
40 pages
Medicated Skin Care in Mexico
US$ 990.00
... , are capitalising on this epidemic, launching several new... Euromonitor International's Medicated Skin Care in Mexico report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
49 pages
Medicated Skin Care in Venezuela
US$ 990.00
... . These categories benefit from large-scale advertising... Euromonitor International's Medicated Skin Care in Venezuela report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
30 pages
Medicated Skin Care in Japan
US$ 990.00
... level of stress is rising and an associated reduction in the... Euromonitor International's Medicated Skin Care in Japan report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
48 pages
CELGENE – Revlimid Sales Disappoints, but Long Term Prospects Intact!
US$ 90.00
Though Q1’12 earnings were disappointing (flat growth of Revlimid), we expect Celgene (CELG) should able to meet its FY12 guidance (Total rev.: $5.4-$5.6b ... read our report released on 27th April, 2012 on CELG titled, “Revlimid Sales Disappoints, but Long Term Prospects Intact!”
April 2012
4 pages
Cosmeceuticals in the U.S, 6th Edition
US$ 3,750.00
... growth in 2010 and 4% growth in 2011. This upswing puts U.S. retail sales of cosmeceuticals at $9.7 billion in 2011, with ongoing annual sales gains expected to boost ... completely updated Packaged Facts report examines the market for cosmeceutical products within the context of broader HBC trends in new product ...
April 2012
238 pages
2012 Global APTT Market Outlook: Test Volume Forecasts by Country and Market Segment
US$ 3,080.00
... APTT testing closer to the patient, creating additional opportunities and challenges for suppliers.This report presents a detailed analysis of the APTT testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as ...
April 2012
198 pages
2012 Global D-Dimer Market Outlook: Test Volume Forecasts by Country and Market Segment
US$ 3,080.00
... Dimer testing closer to the patient, creating additional opportunities and challenges for suppliers.This report presents a detailed analysis of the D-Dimer testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well ...
April 2012
197 pages
2012 Global Heparin Market Outlook: Test Volume Forecasts by Country and Market Segment
US$ 3,080.00
... testing closer to the patient, creating additional opportunities and challenges for suppliers.This report presents a detailed analysis of the Heparin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- ...
April 2012
200 pages
INCYTE: Cheers for INCY - JAKAVI Receives CHMP Nod!
US$ 90.00
Incyte/ Novartis’ JAKAVI (ruxolitinib, JAK 1/2 inhibitor, Registered for MF; PhII ... triggers $40m milestone payment from Novartis (Ex-US rights), and INCY will received a second payment of $60m upon an achievement ... our report released on April 20, 2012 on INCY, titled “Cheers for INCY - JAKAVI Receives CHMP Nod!”
April 2012
2 pages
Medicated Skin Care in Hong Kong, China
US$ 990.00
... occurrences of skin diseases or symptoms in Hong Kong will continue to see growth in medicated skin care due to stressful lifestyle, diseases, erratic weather conditions, etc. Euromonitor International's Medicated Skin Care in Hong Kong, China ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
20 pages
Medicated Skin Care in Ecuador
US$ 990.00
... any measures to prevent the consequences. This has... Euromonitor International's Medicated Skin Care in Ecuador report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
22 pages
Medicated Skin Care in Belarus
US$ 990.00
... . Rising urban population and stress levels in Belarus also resulted in an increase in the incidence of skin... Euromonitor International's Medicated Skin Care in Belarus report offers a comprehensive guide to the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
35 pages
Weight Management in Belarus
US$ 900.00
... to obesity products, which are only available in... Euromonitor International's Weight Management in Belarus report offers a comprehensive guide to the size and shape ... data. Why buy this report? Get a detailed picture of the Weight Management market; Pinpoint growth sectors and identify factors driving ...
April 2012
23 pages
Medicated Skin Care in Turkey
US$ 990.00
... are usually cosmetic products rather than medicines. Euromonitor International's Medicated Skin Care in Turkey report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
28 pages
Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
US$ 3,700.00
... to Susan Eustis, lead author of the study, 'Reimbursement drives power wheelchair markets'. As people and governments pay for medical insurance more money ... , permitting the patient to control mobility for the rehabilitation efforts. Power wheel chairs give patients the ability to control movement. Transport ...
April 2012
467 pages
REGENERON: Tapping Other TRAPS in 3Q12 - ZALTRAP and ARCALYST!
US$ 90.00
... with Bayer for Ex-US, wet AMD) launch skyrocketed Regeneron (REGN); we expect other TRAP based products in the pipeline to sustain this ... Sanofi granted A Priority Review for ZALTRAP (VEGF trap/ aflibercept, R, mCRC – 2nd-line; PhII/ ... 5, 2012 on REGN, titled “Tapping Other TRAPS in 3Q12 - ZALTRAP and ARCALYST!”
April 2012
5 pages
Medicated Skin Care in France
US$ 990.00
... drugs and Rx medicines because they are reimbursed. Euromonitor International's Medicated Skin Care in France report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
42 pages
Medicated Skin Care in the US
US$ 990.00
... diapers, which increases the incidence of diaper rash. Euromonitor International's Medicated Skin Care in USA report offers a comprehensive guide to the size and shape ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
April 2012
53 pages
Healthcare Industry Deal Directory - Edition Q4'2011
US$ 350.00
The healthcare database provides access to all the Mergers and Acquisitions (M&A), Private Equity and Venture Capital Deals since 2004. The database is categorized into various sub-sectors includi...
April 2012
Global Home Healthcare Device Industry 2012 - 2017: Trend, Profit, and Forecast Analysis
US$ 1,980.00
... the face of global home healthcare device industry. Lucintel’s study provides a concise overview of the global home healthcare device industry. The report tracks four regions of global home healthcare device industry. This study ... ) for global home healthcare device industry analysis Gross and net profit trends in the global home healthcare device industry analysis Cost structure trend in the global as well as regional home healthcare device industry ...
April 2012
UAE Healthcare Sector Forecast to 2014
US$ 1,200.00
In the past few years, the UAE healthcare industry has shown an unprecedented growth which is expected to continue in the future due to increasing population, rising prevalence of lifestyle diseases a...
March 2012
135 pages
Saudi Arabian Healthcare Forecast to 2015
US$ 1,000.00
Saudi Arabia represents the largest healthcare market in the GCC region that possesses a huge potential for further expansion due to rising healthcare needs. The government and health regulatory autho...
March 2012
115 pages
G-Protein Coupled Receptors (GPCRs): Market Research Report
US$ 4,500.00
This report analyzes the Global market for G-Protein Coupled Receptors (GPCRs) in US$ Billion. Annual estimates and forecasts are provided for ... through 2017. Also, a six-year historic analysis is provided for this market. The report profiles 43 companies including 7TM Pharma A/S, Actelion Pharmaceuticals ...
March 2012
299 pages
Global RNAi Market Analysis
US$ 1,200.00
RNA Interference (RNAi) has emerged as a breakthrough in the life sciences industry. It presents an extensive potential in multiple areas, such as drug discovery, drug development, and therapeutic app...
March 2012
105 pages
Herpes Simplex Virus Treatment: Market Research Report
US$ 4,600.00
This report analyzes the worldwide markets for Herpes Simplex Virus Treatment in US$ Million. The report provides separate comprehensive analytics for the US, ... , Inc., Novartis International AG, Sanofi, Starpharma Holdings Limited, and Vical. Market data and analytics are derived from primary and secondary ...
March 2012
300 pages
Global Protein Therapeutics Market Forecast to 2015
US$ 1,800.00
Protein-based therapies have found a prominent place in the biopharmaceutical industry since the launch of human insulin product. They have become one of the most effective clinical methods to treat w...
March 2012
160 pages
Therapy Trends: Multiple Sclerosis
US$ 4,995.00
An incisive report and dynamic analyst briefing service delivering insight from the most influential Multiple Sclerosis (MS) Key Opinion Leaders to map the current treatment landscape and analyse futu...
March 2012
160 pages
Market Access: Communicating Value Stories to Payers
US$ 595.00
... affiliate organisations. What strategies are emerging to tackle these challenges? Market Access: Communicating Value Stories to Payers shares up-to-the-minute insights and case studies from ... finding their way through this new environment. Report Overview Market Access: Communicating Value Stories to Payers provides unique, practical insights into how companies can ...
March 2012
46 pages
Roche - GSK - EMILIA: TDM1 ready to take over Tykerb
US$ 90.00
Today, Roche and ImmunoGen announced the topline data from EMILIA study ... T-DMI in this indication and this should come at the expense of GSK’s Tykerb, which is the current standard of care in this setting. This ...
March 2012
3 pages
Opportunities in the Telemedicine Market in India
US$ 1,000.00
Executive
The telemedicine market in India has witnessed significant growth, owing to its potential of providing the world class clinical and medical services to distant and rural locations. The...
March 2012
30 pages
Merck - IMPROVE IT update - Appears trending favorably
US$ 90.00
Today, Merck announced that the Data Safety Monitoring Board has given a go-ahead signal to the IMPROVE-IT after it conducted a pre-specified second interim ... . The company has also indicated that the projected completion of IMPROVE IT by 2013 may change.
March 2012
1 pages
